Cover Up, It's a Code Blue: Protecting Staff Without Compromising Patient Outcomes

被引：0

作者：

Kiley, Brigid ^{[1
]}

Sederstrom, Jane ^{[1
]}

机构：

[1] Mayo Clin, Phoenix, AZ USA

来源：

CRITICAL CARE NURSE | 2022年 / 42卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

EB5

引用

页码：E12 / E12

页数：1

共 50 条

[41] Language Disparity Predicts Poor Patient-Reported Outcomes and Follow-Up in Microsurgical Breast Reconstruction (Withdrawal of Vol 235, Pg S 36, 2022)
Wang, F.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 236 (03) : E9 - E11
[42] Body mass index and in-hospital outcomes in patient's ≥80 years with ST Elevation Myocardial Infarction. Results from low income country without coronary intervention
Alejandro Rodriguez-Ramos, Miguel
Arteaga-Guerra, Dayani
Guillermo-Segredo, Michel
Simancas-Broche, Leonel
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 306 : 11 - 14
[43] S148: Long-term patient-reported outcomes of laparoscopic magnetic sphincter augmentation versus Nissen fundoplication: a 5-year follow-up study
O'Neill, Sean M.
Jalilvand, Anahita D.
Colvin, Jennifer S.
Haisley, Kelly R.
Perry, Kyle A.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2022, 36 (09): : 6851 - 6858
[44] S148: Long-term patient-reported outcomes of laparoscopic magnetic sphincter augmentation versus Nissen fundoplication: a 5-year follow-up study
Sean M. O’Neill
Anahita D. Jalilvand
Jennifer S. Colvin
Kelly R. Haisley
Kyle A. Perry
Surgical Endoscopy, 2022, 36 : 6851 - 6858
[45] Long term follow-up of mandibular distraction osteogenesis in hemifacial microsomia with and without the association of functional appliances - Role of the ethiology of the patient's mandibular hypoplasia on long term "relapse" after distraction
Meazzini, M. C.
Mazzoleni, F.
Bozzetti, A.
PROCEEDINGS OF THE 5TH INTERNATIONAL CONGRESS OF MAXILLOFACIAL AND CRANIOFACIAL DISTRACTION, 2006, : 207 - +
[46] Worker's compensation and no-fault insurance are associated with decreased patient reported outcomes and higher rates of revision at 2 and 5 years follow-up compared to patients with commercial insurance undergoing hip arthroscopy for femoroacetabular impingement
Moore, Michael
Mongomery Jr, Samuel R.
Perez, Jose
Savage-Elliott, Ian
Sundaram, Vishal
Kaplan, Daniel
Youm, Thomas
ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2024, 144 (07) : 3175 - 3184
[47] PATIENT REPORTED OUTCOMES (PRO) OF TALAZOPARIB (TALA) VERSUS PHYSICIAN'S CHOICE OF CHEMOTHERAPY (PCT) IN PATIENTS (PTS) WITH ADVANCED BREAST CANCER (ABC) AND A GERMLINE BRCA (GBRCA) MUTATION: A FOCUS ON EMBRACA PTS WITH/WITHOUT PRIOR CHEMOTHERAPY (CT) SUBGROUPS
Quek, R. G. W.
Bhattacharyya, H.
Goncalves, A.
Rugo, H. S.
Hurvitz, S. A.
Ettl, J.
VALUE IN HEALTH, 2019, 22 : S532 - S532
[48] Worker's compensation and no-fault insurance are associated with decreased patient reported outcomes and higher rates of revision at 2 and 5 years follow-up compared to patients with commercial insurance undergoing hip arthroscopy for femoroacetabular impingement (144, pg 3175, 2024)
Moore, Michael
Montgomery, Samuel R.
Perez, Jose
Savage-Elliott, Ian
Sundaram, Vishal
Kaplan, Daniel
Youm, Thomas
ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2024, 144 (08) : 3907 - 3907
[49] Patient Reported Outcomes (PRO) in patients (pts) with HER2-advanced breast cancer (ABC) and a germline BRCA1/2 mutation (gBRCAm) receiving talazoparib (TALA) vs physician's choice chemotherapy (PCT) in the EMBRACA trial: A focus on subgroups with/without visceral disease
Ettl, J.
Quek, R. G. W.
Bhattacharyya, H.
Rugo, H. S.
Hurvitz, S. A.
Goncalves, A.
ANNALS OF ONCOLOGY, 2019, 30 : 129 - +
[50] Treatment Patterns, Safety, and Patient Reported Outcomes among Adult Women with Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer with or without, or with Unknown, BRCA1/2 Mutation(s): Results of a Real-World Study from the United States, United Kingdom, and four EU Countries
Lux, Michael Patrick
Lewis, Katie
Rider, Alex
Niyazov, Alexander
BREAST CARE, 2022, 17 (05) : 460 - 469

← 1 2 3 4 5 →